End-of-day NAV
$10.01
ASX previous close
Investing in global growth companies
New on Equity Mates 3 September 2026
Knowing when to sell
Michael Frazis joins Equity Mates to discuss managing momentum in faster markets, cracks in the AI infrastructure trade, opportunities in software and biotech, and why Frazis Capital launched the ROAR Active ETF.
Performance and latest file
Market data, returns and daily MPI
The key live fund information is now directly below the hero, with daily market-price returns and the latest Material Public Information file in easy reach.
Last traded price
—
Volume: —
Indicative NAV
—
Updated throughout the day
Daily MPI File
Material Public Information File
Latest published portfolio information for the Lion Active ETF.
Download MPIPerformance
Performance Overview
Market price returns from daily ASX snapshots
1 Month
—3 Months
—6 Months
—Since Inception
—Daily market-price performance updates after the 4:30pm Sydney ASX snapshot. Returns use ASX last traded price and are not NAV performance.
Monthly Updates
June 2026: first full month in the books
ROAR's June update and first monthly factsheet are here, with the return, closing NAV, sector weights and top holdings up front.
The largest sector weights were cash and fixed income equivalents at 31.7%, health care at 24.2%, information technology at 20.8%, communication services at 7.6%, financials at 5.4%, consumer discretionary at 4.9%, and consumer staples at 3.0%.
Top ten holdings were Omada Health at 3.3%, E L F Beauty at 3.0%, Rubrik at 3.0%, BillionToOne at 3.0%, Amphenol at 2.9%, Agios Pharmaceuticals at 2.9%, Pro Medicus at 2.8%, Kaspi at 2.8%, Life360 at 2.8%, and Taiwan Semiconductor ADR at 2.8%.
June 2026 Monthly Update
ROAR Update: First full month in the books
The June note covers healthcare positioning, selective semiconductor exposure, software watchpoints and how to read the daily MPI releases.
Strategy
Customer love drives market success
We invest in visionary businesses delivering exceptional experiences, supporting sustainable company growth.
We dive deep into the customer relationship, and focus on that key moment when a customer makes a decision—which ultimately determines which businesses thrive and which businesses fail.
Contact us
Technology
We invest across high-impact sectors globally
Technology
Innovators shaping our future
Healthcare
Saving and improving lives at scale
Consumer
Brands defining your everyday experience
risk management
Risk is inevitable. How you handle it defines success.
We cut risk at clearly defined levels to avoid
extended sell-offs.
We systematically harvest profits.
We re-enter positions where we see opportunities to participate in long-term company growth.
Fundamental research identifies global leaders . Quantitative research manages the risks.
At Lioncrest Partners, rigorous risk management is integral to our strategy. We scale our portfolio up and down proactively as market conditions change.
Our in-house engineers have built and refined our proprietary risk systems to help manage the risks associated with investing in global growth companies.
Contact us
At Lioncrest Partners, rigorous risk management is integral to our strategy. We scale our portfolio up and down proactively as market conditions change.
Our in-house engineers have built and refined our proprietary risk systems to help manage the risks associated with investing in global growth companies.
